Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women
- PMID: 28285651
- DOI: 10.1016/j.metabol.2016.12.015
Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women
Abstract
Background: Increased intestinal permeability with subsequent metabolic endotoxemia, i.e., elevated circulating levels of bacterial lipopolysaccharide, LPS, has been introduced as a novel initiator of obesity related metabolic disturbances in non-pregnant individuals. The objective was to investigate the extent to which intestinal permeability, measured by serum zonulin concentration, is related to metabolic endotoxemia and metabolic risk markers in overweight pregnant women.
Methods: This was a cross-sectional study including 100 pregnant overweight women in early pregnancy. Serum zonulin was analyzed using ELISA, and markers for metabolic endotoxemia (LPS), inflammation (high-sensitive C-reactive protein and glycoprotein acetylation GlyA), glucose metabolism (fasting glucose and insulin), and lipid metabolism were measured.
Results: Higher serum zonulin concentration associated positively with LPS (P=0.02), inflammatory markers (P<0.001), insulin (P<0.001), insulin resistance (P<0.001), and triglycerides (P=0.001), and negatively with insulin sensitivity (P=0.001) (ANOVA with Tukey's corrections or Kruskal-Wallis nonparametric test with Bonferroni correction for zonulin quartiles). All the observed associations were confirmed (P<0.015) in a linear regression model adjusted with potential confounding factors. Both LPS and GlycA showed positive relationship with insulin resistance, serum insulin, triglycerides, total and LDL-cholesterol and negative relationship with insulin sensitivity (P≤0.03) in the univariate linear regression. Positive relationship was also found between LPS and HDL-cholesterol (P=0.03).
Conclusions: Our findings suggest that increased serum zonulin concentration, i.e., increased intestinal permeability, contributes to metabolic endotoxemia, systemic inflammation, and insulin resistance in overweight pregnant women. By reinforcing intestinal barrier, it may be possible to manipulate maternal metabolism during pregnancy with subsequent health benefits.
Keywords: Intestinal permeability; Low grade inflammation; Metabolic endotoxemia; Overweight; Pregnancy.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles.Clin Nutr. 2018 Dec;37(6 Pt A):1955-1966. doi: 10.1016/j.clnu.2017.12.013. Epub 2017 Dec 27. Clin Nutr. 2018. PMID: 29338886
-
Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents.Clin Chim Acta. 2018 Jun;481:218-224. doi: 10.1016/j.cca.2018.03.005. Epub 2018 Mar 12. Clin Chim Acta. 2018. PMID: 29544751
-
Gut Microbiota Richness and Composition and Dietary Intake of Overweight Pregnant Women Are Related to Serum Zonulin Concentration, a Marker for Intestinal Permeability.J Nutr. 2016 Sep;146(9):1694-700. doi: 10.3945/jn.116.235358. Epub 2016 Jul 27. J Nutr. 2016. PMID: 27466607
-
Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation.Biochimie. 2011 Jan;93(1):39-45. doi: 10.1016/j.biochi.2010.04.016. Epub 2010 Apr 28. Biochimie. 2011. PMID: 20433893 Review.
-
Metabolic endotoxemia with obesity: Is it real and is it relevant?Biochimie. 2016 May;124:11-20. doi: 10.1016/j.biochi.2015.06.020. Epub 2015 Jun 29. Biochimie. 2016. PMID: 26133659 Free PMC article. Review.
Cited by
-
Fasting and meal-related zonulin serum levels in a large cohort of obese children and adolescents.Front Endocrinol (Lausanne). 2024 Feb 8;15:1329363. doi: 10.3389/fendo.2024.1329363. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38405153 Free PMC article.
-
Effect of Probiotic Supplementation on Intestinal Permeability in Overweight and Obesity: A Systematic Review of Randomized Controlled Trials and Animal Studies.Adv Nutr. 2024 Jan;15(1):100162. doi: 10.1016/j.advnut.2023.100162. Epub 2023 Dec 8. Adv Nutr. 2024. PMID: 38072119 Free PMC article. Review.
-
Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions.Int J Mol Sci. 2023 Apr 19;24(8):7548. doi: 10.3390/ijms24087548. Int J Mol Sci. 2023. PMID: 37108711 Free PMC article. Review.
-
Microbiome and Diet in Colon Cancer Development and Treatment.Cancer J. 2023 Mar-Apr 01;29(2):89-97. doi: 10.1097/PPO.0000000000000649. Cancer J. 2023. PMID: 36957979 Free PMC article.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
